Jiangsu Hansoh Pharmaceutical Group Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is MICAFUNGIN SODIUM, with a corresponding US DMF Number 36296.
Remarkably, this DMF maintains an Active status since its submission on January 20, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 09, 2022, and payment made on December 09, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II